Abstract:Objective To evaluate the ¿n vitro antibacterial activity of cefoselis against common clinical bacteria, including gram-positive and-negative microorganisms. Methods A total of 849 nonduplicate bacterial strains were collected from 15 teaching hospitals in China during 2008. The minimum inhibitory concentrations (MICs) of cefoselis and other common antibiotics were determined by agar dilution method. Results About 62. 9% to 100% of the non-ESBLs producing strains of E. coli, K. pneumoniae, P. mirabilis, C. /reundii, E. aero genes, E. cloacae, S. marcescens and P. vulgaris were susceptible to cefoselis. The MIC50 values ranged from 0. 016 and 4 mg/L. As for the ESBLs producing strains of E. coli, K. pneumoniae and P. mirabilis, 32. 4% to 54. 5% were susceptible to cefoselis. The MIC5o values were between 8 and 32 mg/L. In addition, 54. 5% of A. baumannii strains and 45. 5% of P. aeruginosa strains were susceptible to cefoselis. The MIC5o of cefoselis for A. baumannii and P. aeruginosa was 4 and 16 mg/L, respectively. The antibacterial activity of cefoselis against S. maltophilia and B. cepacia was poor. The percentage of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) susceptible to cefoselis was 100% and 17. 1%, respectively. The corresponding MIC5o values were 1 and 16 mg/L, respectively. About 87. 2% of penicillin-susceptible S. pneumoniae (PSSP), 40. 5% of penicillin-intermediate S. pneumoniae (PISP) and 51. 6% of penicillin-resistant S. pneumoniae strains were susceptible to cefoselis, and the corresponding MIC5o value was 0. 016 mg/L, 4 mg/L, and 1 mg/L, respectively. The antibacterial activity of cefoselis against S. pneumoniae was superior to cefepime. Conclusions Cefoselis demonstrates a very high antibacterial activity against most Enterobacteriaceae bacteria, which is superior to cefotaxime and ceftriaxone. Cefoselis is better than cefepime in terms of in vitro antibacterial activity against gram-positive coccus.

In vivo antibacterial effect of cefathiamidine against mouse septicemia

Pharmacokinetic Profile of Cefoselis Sulfate in Mice Brain

A multicenter study on the in vitro antibacterial activity of cefoselis against common clinical bacteria

In vivo activity of cefcapene proxetil in the experimental motel of mouse septicemia infected by bacteria

The Effect of Cefazedone Sodium on Mice Infected by Clinically Isolated Bacteria

Treatment effects of the combination of cefuroxime and tazobactam against mouse septicemia infected by β-lactamases producing strains

In vivo therapeutic efficacy of cefdinir (FK482), a new oral cephalosporin, against Staphylococcus aureus and Haemophilus influenzae in mouse infection models

Antibacterial Activities of Different Concentration Ratio of Cefotaxim-Sulbactam Against the Pathogenic Microorganisms

Study on minimum inhibitory concentrations and its influence factors of cefathiamidine

In vivo activity of tedizolid phosphate injection

Pharmacodynamics of Cefquinome in a Neutropenic Mouse Thigh Model of Staphylococcus Aureus Infection

Efficacy of experimental comparison on three generations cephalosporins

The pharmacokinetics and pharmacodynamics of cefquinome against Streptococcus agalactiae in a murine mastitis model

Protecting effect of levofloxacin mesylate on systemic infections in mice

In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis Following Intramammary Infusion.

The in Vivo Antibacterial Activity of Amoxicillin-Clavulanic Acid in Mouse Septicemia Model

The pharmacokinetics and pharmacodynamics of cefquinome against <i>Streptococcus agalactiae</i> in a murine mastitis model

In vivo activity of antibiotic 89-07 combined with flomoxef in the experimental therapy of mouse septicemia infected by mec A gene positive MRSA

Pharmacokinetic/Pharmacodynamic Analysis of the Activity of Cefquinome when used to treat Streptococcus agalactiae in a Murine Mastitis Model

Dose Assessment of Cefquinome by Pharmacokinetic/Pharmacodynamic Modeling in Mouse Model of Staphylococcus aureus Mastitis.

[The Antibacterial Effect of Cecropin B on Pseudomonas Aeruginosa Infection of Wounds in Mice].